These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 650942)

  • 1. [Moyamoya disease (abnormal vascular network at the base of the brain)--epidemiological and etiological studies].
    Nishimoto A
    Nihon Rinsho; 1978; 36(3):614-20. PubMed ID: 650942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Moyamoya disease--clinicopathological and etiological aspects].
    No Shinkei Geka; 1983 Dec; 11(12):1248-58. PubMed ID: 6669212
    [No Abstract]   [Full Text] [Related]  

  • 3. Moyamoya disease caused by leptospiral cerebral arteritis.
    Liu XM; Ruan XZ; Cai Z; Yu BR; He SP; Gong YH
    Chin Med J (Engl); 1980 Sep; 93(9):599-604. PubMed ID: 6775894
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pathology and clinical features of the abnormal vascular network at the base of the brain- report of 3 cases with post-mortem examination (author's transl)].
    Liu DS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980; 13(3):129-31. PubMed ID: 7438898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple progressive cerebral arterial stenoses, stenosis of renal artery and Recklinghausen's disease. Apropos of a case of moyamoya in an infant].
    Gilly R; Elbaz N; Langue J; Raveau J
    Pediatrie; 1982; 37(7):523-30. PubMed ID: 6820491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case-control study of moyamoya disease].
    Yamaguchi T; Matsushima Y; Takada Y; Niimi Y; Umezu R; Fukuyama Y; Yamaguchi M; Inaba Y
    No To Shinkei; 1989 May; 41(5):485-91. PubMed ID: 2803821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and radiological analysis of the abnormal vascular network of the base of the brain].
    Wang KH; Ten YJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980; 13(3):132-5. PubMed ID: 7438899
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain base abnormal vascular network. Clinical and radiologic analysis of 27 cases.
    Wang GX; Tan YJ; Xia QG
    Chin Med J (Engl); 1983 Aug; 96(8):583-90. PubMed ID: 6416755
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological and clinical features of Moyamoya disease in Nanjing, China.
    Miao W; Zhao PL; Zhang YS; Liu HY; Chang Y; Ma J; Huang QJ; Lou ZX
    Clin Neurol Neurosurg; 2010 Apr; 112(3):199-203. PubMed ID: 20004511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey.
    Kuriyama S; Kusaka Y; Fujimura M; Wakai K; Tamakoshi A; Hashimoto S; Tsuji I; Inaba Y; Yoshimoto T
    Stroke; 2008 Jan; 39(1):42-7. PubMed ID: 18048855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features of moyamoya disease in Japan.
    Hoshino H; Izawa Y; Suzuki N;
    Neurol Med Chir (Tokyo); 2012; 52(5):295-8. PubMed ID: 22688065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moyamoya disease caused by leptospiral arteritis (author's transl)].
    Liu SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980; 13(3):140-2. PubMed ID: 7438901
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome) in the People's Republic of China.
    Matsushima Y; Qian L; Aoyagi M
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S19-22. PubMed ID: 9409398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor associated with Moyamoya disease: a case report.
    Watanabe Y; Todani T; Fujii T; Toki A; Uemura S; Koike Y
    Z Kinderchir; 1985 Apr; 40(2):114-6. PubMed ID: 2988231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune antibody in moyamoya disease].
    Wanifuchi H; Kagawa M; Takeshita M; Izawa M; Maruyama S; Kitamura K
    No Shinkei Geka; 1986 Jan; 14(1):31-5. PubMed ID: 3485262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical prognosis and therapeutic aspects in management of pediatric moyamoya disease].
    Tamogami R; Oi S; Nonaka Y; Miwa T; Abe T
    Nihon Rinsho; 2010 Jan; 68(1):45-52. PubMed ID: 20077789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging in moyamoya disease].
    Fujita K; Shirakuni T; Kojima N; Tamaki N; Matsumoto S
    No Shinkei Geka; 1986 Mar; 14(3 Suppl):324-30. PubMed ID: 3703130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and outcomes in patients with asymptomatic moyamoya disease--from the results of nation-wide questionnaire survey].
    Yamada M; Fujii K; Fukui M
    No Shinkei Geka; 2005 Apr; 33(4):337-42. PubMed ID: 15830539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of Moyamoya disease by superficial temporal-middle cerebral artery (STA-MCA) anastomosis.
    Erickson DL; Koivukangas J
    Ann Clin Res; 1986; 18 Suppl 47():21-4. PubMed ID: 3813465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.